TY  - RPRT
TI  - FDA introductory comments: clinical studies design and evaluation issues.
AU  - Janet Woodcock
PY  - 2005
DO  - 10.1191/1740774505cn096oa
UR  - https://pubmed.ncbi.nlm.nih.gov/16281424/
ID  - 16281424
ER  -